Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Working Capital Changes: 2013-2024

Historic Other Working Capital Changes for Collegium Pharmaceutical (COLL) over the last 12 years, with Dec 2024 value amounting to $14.1 million.

  • Collegium Pharmaceutical's Other Working Capital Changes fell 5016.36% to -$21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 83.86%. This contributed to the annual value of $14.1 million for FY2024, which is 1077.76% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Other Working Capital Changes is $14.1 million, which was up 1,077.76% from -$1.4 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Other Working Capital Changes high stood at $14.1 million for FY2024, and its period low was -$1.4 million during FY2023.
  • For the 3-year period, Collegium Pharmaceutical's Other Working Capital Changes averaged around $5.7 million, with its median value being $4.6 million (2022).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 131.24% in 2023, then skyrocketed by 1,077.76% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Other Working Capital Changes (Yearly) stood at $1.6 million in 2020, then crashed by 32.04% to $1.1 million in 2021, then surged by 324.13% to $4.6 million in 2022, then slumped by 131.24% to -$1.4 million in 2023, then soared by 1,077.76% to $14.1 million in 2024.